These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4971071)

  • 41. The present prophylactic trends of rubella and measles.
    Zardi O; Soubotian B
    Biochem Exp Biol; 1979; 15(3):223-8. PubMed ID: 555675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on measles in Thailand. 1. Seroepidemiological examination.
    Ueda S; Okuno Y; Sangkawibha N; Jayavasu J; Tuchinda P
    Biken J; 1967 Sep; 10(3):129-33. PubMed ID: 6081221
    [No Abstract]   [Full Text] [Related]  

  • 43. Assay of rubella antibodies by immunofluorescence, complement fixation and neutralization.
    Gispen R; Brand-Saathof B
    Arch Gesamte Virusforsch; 1967; 21(3):334-48. PubMed ID: 4878754
    [No Abstract]   [Full Text] [Related]  

  • 44. Serology of rubella. Virus neutralization, immunofluorescence in BHK21 cells, and hemagglutination inhibition.
    Deibel R; Cohen SM; Ducharme CP
    N Y State J Med; 1968 Jun; 68(11):1355-62. PubMed ID: 4870797
    [No Abstract]   [Full Text] [Related]  

  • 45. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 46. Seroepidemiology of rubella and reinfection.
    Enders-Ruckle G
    Am J Dis Child; 1969 Jul; 118(1):139-42. PubMed ID: 5790241
    [No Abstract]   [Full Text] [Related]  

  • 47. The epidemiology of rubella disease in Ethiopia: data from the measles case-based surveillance system.
    Mitiku K; Bedada T; Masresha B; Kegne W; Nafo-Traoré F; Tesfaye N; Beyene B
    J Infect Dis; 2011 Jul; 204 Suppl 1():S239-42. PubMed ID: 21666167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Differences in rubella immunity in Mali and Hamburg and their consequences].
    Ehrengut W; AgRhaly A; Förster A; Koumaré B; Diallo D
    Klin Padiatr; 1984; 196(6):378-81. PubMed ID: 6392722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prevalence of rubella infection in Somalia.
    Morandi N; Gemme G; Miletich F; Ahmed Farah A; Terragna A
    Trop Med Parasitol; 1986 Sep; 37(3):298-9. PubMed ID: 3787125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of antibodies against rubella virus in Spain.
    Eiros Bouza JM; Luquero Alcalde FJ; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu Leonardo RO
    Clin Infect Dis; 2007 Feb; 44(3):465-6. PubMed ID: 17205464
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical, epidemiological and sero-virological studies on rubella.
    Okuni H; Nakamura O; Harima Y; Takasu A; Gamo I
    Med J Osaka Univ; 1974 Dec; 25(1-2):33-42. PubMed ID: 4468375
    [No Abstract]   [Full Text] [Related]  

  • 54. The occurrence of neutralizing and complement fixing antibodies in rubella.
    Field AM
    J Hyg (Lond); 1967 Sep; 65(3):409-21. PubMed ID: 5233992
    [No Abstract]   [Full Text] [Related]  

  • 55. [Epidemiological studies of rubella and cytomegalovirus infection in the North of the USSR].
    Kantorovich RA; Kozlov VG; Ral'f NM; Zhuravel' GF; Agafonov VM; Tenditnaia LV
    Vopr Virusol; 1980; (2):191-5. PubMed ID: 6247846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Virology and epidemiology of rubella.
    Am J Dis Child; 1969 Jul; 118(1):146-54. PubMed ID: 5797279
    [No Abstract]   [Full Text] [Related]  

  • 57. High incidence of adults with rubella antibody in northern Japan.
    Suto T; Morita M; Hinuma Y; Ishida N
    Jpn J Microbiol; 1971 Mar; 15(2):143-7. PubMed ID: 5314130
    [No Abstract]   [Full Text] [Related]  

  • 58. A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus.
    Kanbayashi D; Kurata T; Takahashi K; Kase T; Komano J
    J Virol Methods; 2018 Feb; 252():86-93. PubMed ID: 29191395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maternal and congenital rubella before 1964: frequency, clinical features, and search for isoimmune phenomena.
    White LR; Sever JL; Alepa FP
    J Pediatr; 1969 Feb; 74(2):198-207. PubMed ID: 4178705
    [No Abstract]   [Full Text] [Related]  

  • 60. Seroepidemiological study of rubella in Calcutta.
    Chakravarty MS; Gupta B; Das BC; Mukherjee MK; Mitra AC; Sarkar JK
    Indian J Med Res; 1976 Jan; 64(1):87-92. PubMed ID: 1270103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.